NCT05711823 Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC Status NOT_YET_RECRUITING Phase PHASE3
NCT05705791 Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT05704192 CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302) Status UNKNOWN Phase N/A
NCT05703750 Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301) Status UNKNOWN Phase N/A
NCT05701553 Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma Status RECRUITING Phase N/A
NCT05690451 Non-contrast Abbreviated MRI for Secondary Surveillance of HCC Status COMPLETED Phase N/A
NCT05687747 Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma Status RECRUITING Phase PHASE1
NCT05681949 Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards Status UNKNOWN Phase NA
NCT05675462 Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma Status RECRUITING Phase PHASE1
NCT05670561 Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma Status UNKNOWN Phase PHASE4
NCT05669339 AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT05668793 GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method) Status UNKNOWN Phase N/A
NCT05666271 Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05662488 FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy Status UNKNOWN Phase N/A
NCT05657249 Alternative Surveillance Program for Patients With High Risk Group of HCC Status ACTIVE_NOT_RECRUITING Phase NA
NCT05652920 Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC Status RECRUITING Phase PHASE1/PHASE2